Skip to main content
. 2015 Jun 26;25(Suppl Suppl 1):79–87. doi: 10.1002/pds.3822

Figure 3.

Figure 3

Co‐medication adjusted risk of hip/femur fracture associated to duration of current use of BZD in CPRD. Case‐crossover study